Lower urinary tract symptoms, often shortened to LUTS, are a group of experiences rather than one diagnosis. They can include urgency, frequency, getting up at night to urinate, a weak stream or straining.
A large twin study asked a narrower scientific question: how much of the variation in these symptoms among middle-aged men was associated with inherited differences, and how much remained outside the genetic component?
Quick answer
How heritable are lower urinary tract symptoms in men?
In 1,002 monozygotic and 580 dizygotic middle-aged male twin pairs, the total International Prostate Symptom Score had an estimated heritability of 37% (95% CI 32–42%). That supports a moderate inherited contribution while leaving substantial variation to non-genetic influences.
Key takeaways
- The study used the International Prostate Symptom Score (I-PSS), a symptom questionnaire rather than a diagnosis.
- Total I-PSS heritability was estimated at 37% in this middle-aged male twin cohort.
- Individual symptoms differed: estimates ranged from 21% for nocturia to 40% for straining.
- Frequency and urgency showed moderate heritability estimates of roughly 34–36%.
- LUTS can have multiple causes, so a heritability estimate cannot tell an individual man what is causing his symptoms.
What “lower urinary tract symptoms” actually means
LUTS is an umbrella term for urinary symptoms such as urgency, frequency, nocturia and difficulty with urine flow. The Afari study deliberately measured symptoms with the I-PSS rather than assigning every participant a single underlying diagnosis.
That distinction is important: similar symptoms can arise in different clinical contexts, so symptom research should not be converted into a prostate diagnosis.
The twin design and the 37% estimate
Afari and colleagues analysed members of the Vietnam Era Twin Registry: 1,002 monozygotic and 580 dizygotic male twin pairs with a mean age of about 50 years.
Monozygotic and dizygotic similarity was compared using biometric models. The total I-PSS heritability estimate was 37%, with a 95% confidence interval of 32–42%.
Different urinary symptoms had different patterns
The genetic contribution was not identical across every I-PSS item. Nocturia had the lowest reported heritability estimate at 21%, while straining was estimated at 40%. Frequency and urgency were in the mid-30% range.
That spread argues against treating male urinary symptoms as one biologically uniform trait.
Age, environment and everything the model does not name
A twin model partitions variation statistically; it does not produce a list of the specific non-genetic causes operating in each participant. The remaining variation can include person-specific exposures, health conditions, behaviours, biological changes and measurement effects.
The study therefore supports both inherited susceptibility and substantial non-genetic contribution. It does not prove that the non-genetic share is fully preventable or lifestyle-driven.
Symptoms are not a diagnosis
A symptom score can describe burden and patterns in a research population, but it cannot identify the cause of urinary symptoms in an individual. LUTS should not be equated automatically with benign prostate enlargement, prostatitis or prostate cancer.
New, persistent or concerning urinary symptoms belong in an appropriate clinical assessment rather than being explained by a population heritability estimate.
TwinPare perspective: one symptom cluster, several layers of causation
The useful twin-science lesson is not that urinary symptoms are “37% genetic”. It is that inherited susceptibility is measurable while a large share of variation remains outside the additive genetic component in this cohort.
That is the kind of nuance TwinPare Research aims to preserve: population evidence can sharpen questions without pretending to diagnose the person reading it.
Source notes
The source has been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [afari-2016] Heritability of Lower Urinary Tract Symptoms in Men: A Twin Study Niloofar Afari et al.. Journal of Urology, 2016. Evidence type: Classical twin study of 1,002 monozygotic and 580 dizygotic middle-aged male twin pairs using the International Prostate Symptom Score Limitation: Total I-PSS heritability was estimated at 37% (95% CI 32–42%). Individual symptom estimates ranged from 21% for nocturia to 40% for straining. These are population variance estimates and LUTS are symptoms, not a diagnosis of a specific prostate condition. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Do not diagnose BPH, prostatitis, bladder disease or prostate cancer from LUTS or this twin study.
- Do not interpret 37% heritability as an individual genetic percentage.
- Do not provide medication, procedure or screening recommendations.
| ID | Claim | Source support | Caution |
|---|